Abstract:Objective. In order to find the best process for the preparation of Chrysophanol-Pluronic F127 nanomicelles in the laboratory, the preparation of Chrysophanol-Pluronic F127 nanomicelles was optimized using the central composite design method. In order to investigate the properties of the prepared Chrysophanol-Pluronic F127 nanomicelles, physicochemical properties were examined and in vitro dissolution experiments were performed, and the pharmacokinetics of Chrysophanol and Chrysophanol-Pluronic F127 nanomicelles were investigated in rabbits. Methods. In the preexperimental study, the best physical solubilization method and organic solvent for Chrysophanol were selected. The ratio of drug dosage to excipient dosage and the amount of organic solvents were evaluated by single-factor test. Based on the single-factor test, the optimal prescription was obtained by screening the formulation and optimizing the preparation process using the central composite design method with the encapsulation efficiency as the index. Chrysophanol-Pluronic F127 nanomicelles were prepared according to the optimal prescription, and their particle size, potential, appearance, and in vitro release experiments were carried out. Chrysophanol and Chrysophanol-Pluronic F127 nanomicelles were injected intravenously through the ear margins to rabbits, and the drug concentrations in the blood were measured at different time points by HPLC. The obtained blood concentration data were fitted with PK Solver 2.0 program to obtain pharmacokinetic parameters. Results. In the preexperimental study, ultrasonic method was selected as the physical solubilization method, and acetone was selected as the organic solvent. In single-factor test, the highest encapsulation efficiency was achieved when the ratio of drug dosage to excipient dosage was 1 : 15; the highest encapsulation efficiency was achieved when the amount of organic solvent (acetone) was 8 mL. The equation fitted to the model for the optimized prescription by the central composite design method is as follows: R 1 = − 166.93629 + 16.86478 A + 32.55582 B − 0.169750 AB − 0.482675 2 − 2.25797 B 2 R 2 = 0.9457 . The best prescription for the preparation of Chrysophanol-Pluronic F127 nanomicelles was obtained in the ratio of drug dosage to excipient dosage of 1 : 16.309 and the dosage of organic solvent was 6.595 mL. The prepared nanomicelles have a particle size of 152.8 nm and a potential of -23.9 mV. It was observed by transmission electron microscope that the prepared nanomicelles are uniform and spherical in appearance. The drug metabolism of Chrysophanol and nanomicelles in rabbits conforms to the two-compartment open model, and both of them show linear kinetics in the drug dose range. T 1 / 2 α was 0.31 ± 0.21 h and 0.47 ± 0.35 -Abstract Truncated-

Optimal Preparation of Pranlukast-Phospholipid Complex with Central Composite Design-Response Surface Methodology

Response surface methodology for the optimization of lactoferrin nano-liposomes

Glycyrrhizic Acid-Phospholipid Complex: Preparation Process Optimization and Therapeutic and Pharmacokinetic Evaluation in Rats

Response Surface Methodology for the Optimization of Beta-Lactoglobulin Nano-Liposomes

Optimization of Fabrication Parameters to Prepare Tea Catechin-Loaded Liposomes Using Response Surface Methodology

Study on Central Composite Design Method to Optimize the Preparation Process of Chrysophanol-Pluronic F127 Nanomicelles and Pharmacokinetics

Optimization of bacteriocin production by a new Lactobacillus strain, ZJ317, using response surface methodology

Enhance the Dissolution Rate and Oral Bioavailability of Pranlukast by Preparing Nanosuspensions with High-Pressure Homogenizing Method

Enhancement of Solubility, Transport Across Madin-Darby Canine Kidney Monolayers and Oral Absorption of Pranlukast Through Preparation of a Pranlukast-Phospholipid Complex

Optimization of Cudrania Extractum Tablets Formulation by Central Composite Design-Response Surface Methodology

Study on the Optimal Formulation and Preparation Conditions of Propranolol-loaded Transfersomes by Central Composite Design and Response Surface Method

Optimization of the Intranasal Powders of Panax Notoginseng Saponins by the Central Composite Design-Response Surface Methodology

Process optimization for PHA production by activated sludge using response surface methodology

Optimization of Reaction Conditions for Polyurethane Foam Synthesis with Liquefied Corn Stalk by Response Surface Methodology

Formulation optimization of scutellarin-loaded HP-β-CD/chitosan nanoparticles using response surface methodology with Box–Behnken design

Preparation of chrysin-phospholipid complex and its pharmacokinetic behaviors

Development and evaluation of puerarin-loaded controlled release nanostructured lipid carries by central composite design

Optimization of Epirubicin Liposome Formulation Using Box-Behnken Experimental Design

Optimization of Rhamnolipid Hydrolysis Conditions Using Response Surface Methodology

Optimized the preparation process of thermo-sensitive Yinhuang ophthalimic gel by central composite design-response surface method

Optimized Preparation of Silymarin Dropping Pill by a Central Composite Design-Response Surface Method